Farah Fawaz

Farah Fawaz is a highly experienced professional in the biopharmaceutical industry, currently serving as Senior Vice President at Allogene Therapeutics since October 2018, with a focus on GxP Quality and Compliance and CMC Quality. Prior to this role, Fawaz held the position of Executive Director of Commercial QC at Intarcia Therapeutics, Inc., and spent nearly a decade at Bayer HealthCare in various roles, including Director of Quality Control and Analytical Chemistry. Fawaz began the career as a Senior Scientist at Berlex and previously worked as a Post-doctoral fellow at the University of California, San Francisco. Fawaz holds a Ph.D. in Cellular and Molecular Biology from the University of Michigan and a B.S. in Biology from the American University of Beirut.